Research programme: monoclonal antibodies - ElsaLys BiotechAlternative Names: anti-CD115 monoclonal antibodies - Transgene; ELB-041; TG 3003
Latest Information Update: 20 Dec 2016
At a glance
- Originator Transgene
- Developer ElsaLys Biotech; Transgene
- Class Monoclonal antibodies
- Mechanism of Action Dendritic cell stimulants; Immunostimulants; Macrophage colony-stimulating factor receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation; Solid tumours